Are Routine Postoperative Hemoglobin Tests Justified in All Patients Who Undergo Total Hip Arthroplasty Due to a Displaced Femoral Neck Fracture?
Abstract
:1. Background
2. Methods
2.1. Patients
2.2. Surgical Approach
2.2.1. Direct Anterior Approach
2.2.2. Implants
2.2.3. Surgical Team
2.2.4. Measurements
2.2.5. Data Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sterling, R.S. Gender and Race/Ethnicity Differences in Hip Fracture Incidence, Morbidity, Mortality, and Function. Clin. Orthop. Relat. Res. 2011, 469, 1913–1918. [Google Scholar] [CrossRef] [PubMed]
- Kurtz, S.; Ong, K.; Lau, E.; Mowat, F.; Halpern, M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Jt. Surg. 2007, 89, 780–785. [Google Scholar] [CrossRef]
- Ben Elyahu, R.; Ohana, N.; Agabaria, E.; Biadsi, A.; Segal, D.; Yaacobi, E.; Palmanovich, E.; Markushevich, M.; Brin, Y.S. Direct Anterior vs. Direct Lateral Approach Total Hip Arthroplasty for Displaced Femoral Neck Fracture. J. Clin. Med. 2023, 12, 5019. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Morgan, S.; Jarvis, S.; Conti, A.; Staudinger, K.; Reynolds, C.; Bar-Or, D. Displaced Geriatric Femoral Neck Fractures: A Retrospective Comparison of Total Hip Arthroplasties Versus Hemiarthroplasty. Geriatr. Orthop. Surg. Rehabil. 2023, 14, 21514593231198949. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Yang, Z.-G.; Chen, W.-P.; Wu, L.-D. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: A meta-analysis. J. Bone Jt. Surg. 2012, 94, 1153–1159. [Google Scholar] [CrossRef] [PubMed]
- Browne, J.A.; Adib, F.; Brown, T.E.; Novicoff, W.M. Transfusion rates are increasing following total hip arthroplasty: Risk factors and outcomes. J. Arthroplast. 2013, 28, 34–37. [Google Scholar] [CrossRef] [PubMed]
- Patil, A.; Sephton, B.M.; Ashdown, T.; Bakhshayesh, P. Blood loss and transfusion rates following total hip arthroplasty: A multivariate analysis. Acta Orthop. Belg. 2022, 88, 27–34. [Google Scholar] [CrossRef]
- Lloyd, J.M.; Wainwright, T.; Middleton, R.G. What is the role of minimally invasive surgery in a fast track hip and knee replacement pathway? Ann. R. Coll. Surg. Engl. 2012, 94, 148–151. [Google Scholar] [CrossRef] [PubMed]
- De Carvalho Almeida, R.F.; Serra, H.O.; de Oliveira, L.P. Fast-track versus conventional surgery in relation to time of hospital discharge following total hip arthroplasty: A single-center prospective study. J. Orthop. Surg. Res. 2021, 16, 488. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Büttner, M.; Mayer, A.M.; Büchler, B.; Betz, U.; Drees, P.; Susanne, S. Economic analyses of fast-track total hip and knee arthroplasty: A systematic review. Eur. J. Orthop. Surg. Traumatol. 2020, 30, 67–74. [Google Scholar] [CrossRef] [PubMed]
- Hennessy, O.; McSorley, K. Is Routine Hemoglobin Monitoring Necessary after Elective Hip and Knee Arthroplasty? Arthroplast. Today 2020, 6, 803–806. [Google Scholar] [CrossRef] [PubMed]
- Gilde, A.K.; Downes, K.L.; Leverett, S.; Miranda, M.A. Routine postoperative Complete Blood Counts Are Not Necessary After Most Primary Total Hip and Knee Arthroplasties. J. Arthroplast. 2021, 36, 1257–1261. [Google Scholar] [CrossRef] [PubMed]
- Von Elm, E.; Altman, D.G.; Egger, M.; Pocock, S.J.; Gøtzsche, P.C.; Vandenbroucke, J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007, 370, 1453–1457. [Google Scholar] [CrossRef] [PubMed]
- Realyvasquez, J.; Singh, V.; Shah, A.K.; Ortiz D 3rd Robin, J.X.; Brash, A.; Kurapatti, M.; Davidovitch, R.I.; Schwarzkopf, R. The direct anterior approach to the hip: A useful tool in experienced hands or just another approach? Arthroplasty 2022, 4, 1. [Google Scholar] [CrossRef] [PubMed]
- Craig, J.M.B.B.M.; McDonald, J.M.B.B.M.; Cassidy, R.B.M.; McDonald, S.B.P.; Barr, J.M.F.; Diamond, O. Clinical Outcomes for Hemiarthroplasty Versus Total Hip Arthroplasty in Patients With Femoral Neck Fracture Who Meet Published National Criteria for Total Hip Arthroplasty. J. Orthop. Trauma. 2022, 36, 17–22. [Google Scholar] [CrossRef] [PubMed]
- Prasad, N.; Padmanabhan, V.; Mullaji, A. Blood loss in total knee arthroplasty: An analysis of risk factors. Int. Orthop. 2007, 31, 39–44. [Google Scholar] [CrossRef] [PubMed]
- Hrnack, S.A.; Skeen, N.; Xu, T.; Rosenstein, A.D. Correlation of body mass index and blood loss during total knee and total hip arthroplasty. Am. J. Orthop. 2012, 41, 467–471. [Google Scholar] [PubMed]
- Miao, K.; Ni, S.; Zhou, X.; Xu, N.; Sun, R.; Zhuang, C.; Wang, Y. Hidden blood loss and its influential factors after total hip arthroplasty. J. Orthop. Surg. Res. 2015, 10, 36. [Google Scholar] [CrossRef] [PubMed]
- Walsh, M.; Preston, C.; Bong, M.; Patel, V.; Di Cesare, P.E. Relative Risk Factors for Requirement of Blood Transfusion after Total Hip Arthroplasty. J. Arthroplast. 2007, 22, 1162–1167. [Google Scholar] [CrossRef] [PubMed]
- Ross, D.; Erkocak, O.; Rasouli, M.R.; Parvizi, J. Operative Time Directly Correlates with Blood Loss and Need for Blood Transfusion in Total Joint Arthroplasty. Arch. Bone Jt. Surg. 2019, 7, 229–234. [Google Scholar]
- Kolisek, F.R.; Bonutti, P.M.; Hozack, W.J.; Purtill, J.; Sharkey, P.F.; Zelicof, S.B.; Ragland, P.S.; Kester, M.; Mont, M.A.; Rothman, R.H. Clinical experience using a minimally invasive surgical approach for total knee arthroplasty: Early results of a prospective randomized study compared to a standard approach. J. Arthroplast. 2007, 22, 8–13. [Google Scholar] [CrossRef] [PubMed]
- Petersen, P.B.; Kehlet, H.; Jørgensen, C.C. Improvement in fast-track hip and knee arthroplasty: A prospective multicentre study of 36,935 procedures from 2010 to 2017. Sci. Rep. 2020, 10, 21233. [Google Scholar] [CrossRef] [PubMed]
- Zagra, L. Advances in hip arthroplasty surgery: What is justified? EFORT Open Rev. 2017, 2, 171–178. [Google Scholar] [CrossRef] [PubMed]
- Aasvang, E.K.; Luna, I.E.; Kehlet, H. Challenges in post discharge function and recovery: The case of fast-track hip and knee arthroplasty. Br. J. Anaesth. 2015, 115, 861–866. [Google Scholar] [CrossRef] [PubMed]
- Jansson, M.M.; Harjumaa, M.; Puhto, A.-P.; Pikkarainen, M. Healthcare professionals’ perceived problems in fast-track hip and knee arthroplasty: Results of a qualitative interview study. J. Orthop. Surg. Res. 2019, 14, 294. [Google Scholar] [CrossRef] [PubMed]
- Carling, M.S.; Jeppsson, A.; Eriksson, B.I.; Brisby, H. Transfusions and blood loss in total hip and knee arthroplasty: A prospective observational study. J. Orthop. Surg. Res. 2015, 10, 48. [Google Scholar] [CrossRef] [PubMed]
- Komnos, G.A.; Manrique, J.; Foltz, C.; Klement, M.R.; Restrepo, C.; Parvizi, J. Transfusion rates in total hip arthroplasty are lower in patients with direct anterior approach. Arch. Bone Jt. Surg. 2021, 9, 659–664. [Google Scholar] [PubMed]
- Carson, J.L.; Guyatt, G.; Heddle, N.M.; Grossman, B.J.; Cohn, C.S.; Fung, M.K.; Gernsheimer, T.; Holcomb, J.B.; Kaplan, L.J.; Katz, L.M.; et al. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA 2016, 316, 2025–2035. [Google Scholar] [CrossRef] [PubMed]
- Mitchell, M.D.; Betesh, J.S.; Ahn, J.; Hume, E.L.; Mehta, S.; Umscheid, C.A. Transfusion Thresholds for Major Orthopedic Surgery: A Systematic Review and Meta-analysis. J. Arthroplast. 2017, 32, 3815–3821. [Google Scholar] [CrossRef] [PubMed]
- D’Amore, T.; Loewen, M.; Gorczyca, M.T.; Judd, K.; Ketz, J.P.; Soles, G.; Gorczyca, J.T. Rethinking strategies for blood transfusion in hip fracture patients. OTA Int. 2020, 3, e083. [Google Scholar] [CrossRef] [PubMed]
- Salem-Schatz, S.; Avorn, J.; Soumerai, S.B. Influence of Clinical Knowledge, Organizational Context, and Practice Style on Transfusion Decision Making Implications for Practice Change Strategies. JAMA 1990, 264, 476–483. [Google Scholar] [CrossRef]
PoOHb > 8.5 (n = 170, 96.59%) | PoOHb ≤ 8.5 (n = 6, 3.41%) | Total (n = 176, 100%) | p Value | |
---|---|---|---|---|
Age | 69.23 ± 7.98 | 65 ± 11.85 | 69.09 ± 8.13 | 0.424 |
Sex male | 65 (38.2%) | 2 (33.3%) | 67 (38.1%) | 1.000 |
Time duration from admission to surgery | 0.328 | |||
On the first day of admission | 95 (55.9%) | |||
On the second day of admission | 43 (25.3%) | |||
On the third day of admission | 22 (12.9%) | |||
On the fourth day of admission or later | 10 (5.9%) | |||
Surgery duration (minutes) | 111.76 ± 38.41 | 108 ± 24.17 | 111.63 ± 37.98 | 0.728 |
PrOHb | 13.1 ± 1.36 | 12.5 ± 1.71 | 13.09 ± 1.37 | 0.428 |
PoOHb | 10.62 ± 1.06 | 7.85 ± 0.43 | 10.53 ± 1.16 | <0.001 |
Hb difference following surgery | 2.48 ± 1.18 | 4.65 ± 1.78 | 2.56 ± 1.26 | 0.031 |
Anesthesia general (vs. spinal) | 98 (57.6%) | 5 (83.3%) | 103 (58.5%) | 0.403 |
Hypertension | 86 (50.6%) | 1 (16.7%) | 87 (49.4%) | 0.211 |
Dyslipidemia | 73 (42.9%) | 2 (33.3%) | 75 (42.6%) | 1.000 |
Diabetes mellitus | 39 (22.9%) | 0 (0.0%) | 39 (22.2%) | 0.341 |
Respiratory disease | 16 (9.4%) | 0 (0.0%) | 16 (9.1%) | 1.000 |
Clotting disturbance | 4 (2.4%) | 0 (0.0%) | 4 (2.3%) | 1.000 |
Peripheral vascular disease | 17 (10.0%) | 0 (0.0%) | 17 (9.7%) | 1.000 |
Ischemic heart disease | 28 (16.5%) | 0 (0.0%) | 28 (15.9%) | 0.591 |
Smoking | 26 (15.3%) | 2 (33.3%) | 28 (15.9%) | 0.244 |
BMI | 29 ± 3.58 | 22.92 ± 2.73 | 28.55 ± 2.78 | 0.077 |
Blood transfusion after surgery | 28 (16.5%) | 5 (83.3%) | 28 (15.9%) | <0.001 |
Variable | Did Not Receive Blood Transfusion (n = 143, 81.25%) | Received Blood Transfusion (n = 33, 18.75%) | Total (n = 176, 100%) | p Value |
---|---|---|---|---|
Age | 68.80 ± 8.41 | 70.33 ± 6.75 | 69.09 ± 8.13 | 0.267 |
Sex male | 87 (60.8%) | 22 (66.7%) | 109 (61.9%) | 0.534 |
Time duration from admission to surgery | 0.471 | |||
On the first day of admission | 78 (54.5%) | 21 (63.6%) | 99 (56.3%) | |
On the second day of admission | 38 (26.6%) | 5 (15.2%) | 43 (24.4%) | |
On the third day of admission | 19 (13.3%) | 4 (12.1%) | 23 (13.1%) | |
On the fourth day of admission or later | 8 (5.6%) | 3 (9.1%) | 11 (6.3%) | |
Surgery duration (minutes) | 109.18 ± 37.18 | 122.24 ± 40.14 | 111.63 ± 37.98 | 0.095 |
PrOHb | 13.19 ± 1.36 | 12.63 ± 1.33 | 13.09 ± 1.37 | 0.035 |
PoOHb | 10.79 ± 1.02 | 9.38 ± 1.06 | 10.53 ± 1.16 | <0.001 |
Hb difference following surgery | 2.4 ± 1.17 | 3.25 ± 1.45 | 2.56 ± 1.26 | 0.003 |
Anesthesia general (vs. spinal) | 22 (15.4%) | 11 (33.3%) | 33 (18.7%) | 0.292 |
Hypertension | 71 (49.6%) | 16 (48.5%) | 87 (49.4%) | 0.904 |
Dyslipidemia | 61 (42.7%) | 14 (42.4%) | 75 (42.6%) | 0.981 |
Diabetes mellitus | 33 (23.1%) | 6 (18.2%) | 39 (22.2%) | 0.542 |
Respiratory disease | 16 (11.2%) | 0 (0.0%) | 16 (9.1%) | 0.045 |
Clotting disturbance | 3 (2.1%) | 1 (3.03%) | 4 (2.3%) | 0.568 |
Peripheral vascular disease | 15 (10.5%) | 2 (6.1%) | 17 (9.7%) | 0.743 |
Ischemic heart disease | 22 (15.38%) | 6 (18.18%) | 28 (15.91%) | 0.692 |
Smoking | 23 (16.08%) | 5 (15.15%) | 28 (15.91%) | 0.895 |
BMI | 25.84 ± 4.11 | 25.75 ± 4.29 | 25.62 ± 4.13 | 0.345 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gur, S.; Segal, D.; Tavdi, A.; Fuchs, Y.; Perl, D.; Fainzack, A.; Ohana, N.; Markushevich, M.; Brin, Y.S. Are Routine Postoperative Hemoglobin Tests Justified in All Patients Who Undergo Total Hip Arthroplasty Due to a Displaced Femoral Neck Fracture? J. Clin. Med. 2024, 13, 4371. https://doi.org/10.3390/jcm13154371
Gur S, Segal D, Tavdi A, Fuchs Y, Perl D, Fainzack A, Ohana N, Markushevich M, Brin YS. Are Routine Postoperative Hemoglobin Tests Justified in All Patients Who Undergo Total Hip Arthroplasty Due to a Displaced Femoral Neck Fracture? Journal of Clinical Medicine. 2024; 13(15):4371. https://doi.org/10.3390/jcm13154371
Chicago/Turabian StyleGur, Shanny, David Segal, Alex Tavdi, Yuval Fuchs, Dan Perl, Alon Fainzack, Nissim Ohana, Michael Markushevich, and Yaron Shraga Brin. 2024. "Are Routine Postoperative Hemoglobin Tests Justified in All Patients Who Undergo Total Hip Arthroplasty Due to a Displaced Femoral Neck Fracture?" Journal of Clinical Medicine 13, no. 15: 4371. https://doi.org/10.3390/jcm13154371
APA StyleGur, S., Segal, D., Tavdi, A., Fuchs, Y., Perl, D., Fainzack, A., Ohana, N., Markushevich, M., & Brin, Y. S. (2024). Are Routine Postoperative Hemoglobin Tests Justified in All Patients Who Undergo Total Hip Arthroplasty Due to a Displaced Femoral Neck Fracture? Journal of Clinical Medicine, 13(15), 4371. https://doi.org/10.3390/jcm13154371